Jefferies Lowers PT On Bio-Reference Labs To $21

August 26, 2011 6:10 AM | 8 seconds read |
Jefferies & Company has lowered the price target on Bio-Reference Labs BRLI from $23 to $21 and maintains its Hold rating.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Price TargetAnalyst RatingsHealth CareHealth Care ServicesJefferies & Company
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!